Terms: = Leukemia AND ZNF384, ENSG00000126746, 171017
72 results:
1. EP300-znf384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
Hou Z; Ren Y; Zhang X; Huang D; Yan F; Sun W; Zhang W; Zhang Q; Fu X; Lang Z; Chu C; Zou B; Gao B; Jin B; Kang Z; Liu Q; Yan J
Cell Commun Signal; 2024 Apr; 22(1):211. PubMed ID: 38566191
[TBL] [Abstract] [Full Text] [Related]
2. znf384 fusion transcript levels for measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia.
Shi ZY; Wang X; Chen WM; Li LD; Hao Y; Li JY; Sun K; Zhao XS; Jiang H; Jiang Q; Huang XJ; Qin YZ
Hematol Oncol; 2024 Jan; 42(1):e3251. PubMed ID: 38287528
[TBL] [Abstract] [Full Text] [Related]
3. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
4. Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
Gutierrez-Camino A; Richer C; Ouimet M; Fuchs C; Langlois S; Khater F; Caron M; Beaulieu P; St-Onge P; Bataille AR; Sinnett D
Br J Cancer; 2024 Feb; 130(2):317-326. PubMed ID: 38049555
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic leukemia in an Academic Clinical Laboratory.
Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
[TBL] [Abstract] [Full Text] [Related]
6. Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis.
Kovach AE; Wood BL
Semin Diagn Pathol; 2023 Nov; 40(6):457-471. PubMed ID: 37953192
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical characteristics and outcomes of childhood B-ALL with znf384 and MEF2D rearrangements].
Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
[TBL] [Abstract] [Full Text] [Related]
8. Advances in Flow Cytometry for Mixed Phenotype and Ambiguous leukemias.
Kurzer JH; Weinberg OK
Clin Lab Med; 2023 Sep; 43(3):399-410. PubMed ID: 37481319
[TBL] [Abstract] [Full Text] [Related]
9. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
[TBL] [Abstract] [Full Text] [Related]
10. znf384-Related Fusion Genes in Acute Lymphoblastic leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract] [Full Text] [Related]
11. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract] [Full Text] [Related]
12. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
[TBL] [Abstract] [Full Text] [Related]
13. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
Migita NA; Jotta PY; Nascimento NPD; Vasconcelos VS; Centoducatte GL; Massirer KB; Azevedo AC; Brandalise SR; Yunes JA
Blood Adv; 2023 Jul; 7(13):2957-2971. PubMed ID: 36848637
[TBL] [Abstract] [Full Text] [Related]
14. Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia.
Yu CH; Jou ST; Su YH; Coustan-Smith E; Wu G; Cheng CN; Lu MY; Lin KH; Wu KH; Chen SH; Huang FL; Chang HH; Wang JL; Yen HJ; Li MJ; Chou SW; Ho WL; Liu YL; Chang CC; Lin ZS; Lin CY; Chen HY; Ni YL; Lin DT; Lin SW; Yang JJ; Ni YH; Pui CH; Yu SL; Yang YL
Cancer; 2023 Mar; 129(5):790-802. PubMed ID: 36537587
[TBL] [Abstract] [Full Text] [Related]
15. [The Application of RNA-Sequencing in Pediatric B-Cell Acute Lymphoblastic leukemia].
Zou PL; Liao X; Xiao JW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1700-1707. PubMed ID: 36476892
[TBL] [Abstract] [Full Text] [Related]
16. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
[TBL] [Abstract] [Full Text] [Related]
17. Clinical features and outcomes of fusion gene defined adult Ph-negative B-cell precursor acute lymphoblastic leukemia patients: A single institutional report.
Sun K; Wang J; Chen WM; Xu N; Long LY; Wang X; Jiang H; Jiang Q; Huang XJ; Qin YZ
Biomol Biomed; 2023 Mar; 23(2):298-309. PubMed ID: 36124444
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic activation of the FLT3 gene by znf384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia.
Zhao X; Wang P; Diedrich JD; Smart B; Reyes N; Yoshimura S; Zhang J; Yang W; Barnett K; Xu B; Li Z; Huang X; Yu J; Crews K; Yeoh AEJ; Konopleva M; Wei CL; Pui CH; Savic D; Yang JJ
Nat Commun; 2022 Sep; 13(1):5401. PubMed ID: 36104354
[TBL] [Abstract] [Full Text] [Related]
19. Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic leukemia.
Yu CH; Wu G; Chang CC; Jou ST; Lu MY; Lin KH; Chen SH; Wu KH; Huang FL; Cheng CN; Chang HH; Hedges D; Wang JL; Yen HJ; Li MJ; Chou SW; Hung CT; Lin ZS; Lin CY; Chen HY; Ni YL; Hsu YC; Lin DT; Lin SW; Yang JJ; Pui CH; Yu SL; Yang YL
J Mol Diagn; 2022 Nov; 24(11):1195-1206. PubMed ID: 35963521
[TBL] [Abstract] [Full Text] [Related]
20. Zinc finger protein 384 (
Sudutan T; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Kucukcankurt F; Celkan T; Timur C; Ozdemir GN; Hacısalihoglu S; Gelen SA; Sayitoğlu M
Leuk Lymphoma; 2022 Dec; 63(12):2931-2939. PubMed ID: 35921545
[TBL] [Abstract] [Full Text] [Related]
[Next]
